Cases
Representative Matters: Cannabis: Advised an industry-leading packaging company that services traditional industries with annual global revenues exceeding $2 billion in its expansion of offering packaging materials to the cannabis industry.
Advised a healthcare data
analytics company in connection with its acquisition of a cannabis seed-to-sale tracking company that contracts to provide services to more than a dozen states
foreign governments, with a specific focus on the client's listing on Nasdaq.
Cannabis regulatory counsel for a publicly traded global cannabis company in connection with its U.S. cannabis business interests, including regulatory matters pertaining to a $300 million acquisition of a hemp-derived CBD product manufacturer
the distribution of hemp-derived CBD topicals
vapors in all 50 U.S. states.
Cannabis regulatory counsel for a private credit asset management firm in connection with a $50 million secured financing to a premier producer of packaging
other ancillary products
services to the cannabis
hemp industries.
Cannabis regulatory counsel to a publicly traded manufacturer of industrial pump equipment supplied to the U.S. cannabis industry in connection with its supply contracts
compliance with state
federal cannabis regulations.
Cannabis regulatory counsel for a manufacturer of hemp-derived CBD products in connection with the distribution of its hemp-derived CBD topicals
vapors in convenience store chains in more than two-dozen U.S. states.
Cannabis regulatory counsel for French manufacturer of chromatography equipment supplied to the U.S. cannabis industry with respect to supply contracts
compliance with state
federal cannabis regulations.
Cannabis regulatory counsel for one of the largest internet medical ad networks in connection with advertising cannabis-related businesses using its health market online advertising services.
Represent the Defendants-THC
CBD vaping
infused product manufacturers-in the first ever federal trademark infringement action involving federal trademark rights to use the WOODSTOCK trademark on smoking-related products, including vapor. See Woodstock Ventures LC, et al. v. Woodstock Products Co. International, Inc., et al., SDNY 1:18-cv-01840-RWS
Cannabis regulatory counsel for a Fortune 500 natural gas company in connection with its evaluation of supplying natural gas
related products
equipment to cannabis cultivators
processors.
Cannabis regulatory counsel for a venture capital fund in connection with its investments in California
Massachusetts cannabis operations
real estate holdings pertaining to cannabis operations.
Provide cannabis-related banking
regulatory advice concerning payment systems for cannabis dispensary operations.
Represent THC
CBD infused product manufacturer in documenting a bridge loan for $2,000,000 in operating capital.
Represent THC
CBD infused product manufacturer in connection with corporate restructuring, with a particular emphasis on intellectual property assets
taxation.
Cannabis regulatory counsel for a world-renowned neurosurgeon in connection with a clinical research program involving THC
CBD.
Represent a vertically-integrated operator with licenses in MA, MD,
NH in various aspects of its business, including general corporate, capital raising,
intellectual property.
Cannabis regulatory counsel for a Canadian cannabis fund with subsidiary entities, employees
contractors in California.
Representing a Canadian company in connection with its 20-F Registration filed with the SEC.
Advising one of the world's leading hospitals in connection with their research into the therapeutic benefits of THC
CBD.
Cannabis regulatory counsel to a cannabis-related venture capital fund in the creation of the fund
capital formation activities, as well as advising on portfolio companies in ancillary cannabis businesses.
Advising universities interested in conducting cannabis-related research on the wide range of pertinent regulatory issues.
Representing an applicant for permits to grow, process
dispense medical marijuana pursuant to the clinical registrant provisions of Pennsylvania's Medical Marijuana Act in connection with their applications.
Antitrust: Represents generic pharmaceutical manufacturer in action brought by 40 state attorneys general alleging violations of antitrust
consumer protection laws in connection with the pricing of generic drugs.
Represented osteopaths in a class action alleging that the American Osteopathic Association's conditioning of board certification on the purchase of membership in the Association constituted unlawful tying in violation of antitrust laws. The class action was resolved with an injunction against the AOA preventing their illegal tie, which was found to violate the Sherman Antitrust Act,
future benefits for approximately 100,000 Osteopathic Physicians with a value of around $84 Million.
Obtained summary judgment on behalf of Virtua Health, Inc., a health system of four hospitals in southern New Jersey, against Deborah Heart
Lung Center, a specialty hospital in southern New Jersey, in federal antitrust litigation in which the court held Deborah failed to show any adverse effect on competition in the market.
Counsel to a Philadelphia-area hospital in an action alleging antitrust claims against the region's largest health insurance company arising out of hospital reimbursement rates.
Routinely advises clients in the healthcare
pharmaceutical markets on antitrust issues pertaining to commercial arrangements.
Commercial
Complex Litigation: Appointed by the Court as Lead Counsel
Liaison Counsel on behalf of the defendants in MDL No. 2875, In Re: Valsartan Products Liability Lead Litigation,
individually represent an active pharmaceutical ingredient manufacturer, finished dose manufacturer, distributor
retailers in the action, which alleges personal injury
products liability claims arising out an alleged contaminant in valsartan.
Counsel to a statewide class of emergency room physicians in Tennessee asserting class action claims against a health insurance companies arising out of improper reimbursement for so-called non-emergency services.
Counsel to one of the world's largest private equity firms
a venture capital firm in an action seeking $48 million in damages arising out of the breach of a merger agreement relating to the acquisition of a medical device company
regulatory approval of a medical device.
Counsel to one of the world's largest private equity firms
a venture capital firm in an action seeking $225 million in damages arising out of the breach of a merger agreement relating to the acquisition of a medical device company
regulatory approval of a medical device.
Counsel to a publicly traded medical device manufacturer asserting claims for breach of restrictive covenants
tortious interference with contract against a competitor
former sales representatives.
Counsel to an executive of a publicly traded pharmaceutical manufacturer in an investigation arising out of an alleged violation of restrictive covenants.
Counsel to a statewide class of emergency room physicians in Illinois asserting class action claims against health insurance companies arising out of improper reimbursement for non-contracted services provided to beneficiaries enrolled in the insurer's Medicaid plan.
Counsel to statewide classes of pathologists in Illinois, Texas
Tennessee asserting class action claims in three separate class action arbitrations against a health insurance company arising out of improper reimbursement for contracted services provided to beneficiaries enrolled in the insurer's health care plans.
Counsel to a national class of hospitals asserting class action claims against two insurance companies arising out of improper reimbursement for facility charges, as opposed to professional charges.
Regulatory/Administrative: Representing Virtua Health Inc.
Capital Health System Inc. in a case against the state of New Jersey, seeking to hold unconstitutional as special legislation a law that transfers the right to provide emergency medical services from Virtua
Capital to other hospitals without regard to the established regulatory structure.
Counsel to The Hospital
Healthsystem Association of Pennsylvania in a challenge to a General Appropriations Act that set a default reimbursement rate for out-of-network emergency services provided to enrollees of Medical Assistance managed care organizations
the Supreme Court of Pennsylvania issued a unanimous ruling invalidating the provision in favor of the Duane Morris client.
Securities: Obtained a no-action letter from the SEC on behalf of the Chairman
CEO of an industry-leading company following a multi-year investigation.
Counsel to an executive of a publicly traded company in an SEC investigation
dozens of class actions arising out of alleged disclosure violations concerning the executive's personal business arrangements with the company, the company's accounting for certain commercial transactions
the company's liquidity.
Counsel to an executive of a publicly traded company in class actions arising out of alleged disclosure violations concerning the executive's compensation, as well as other commercial transactions of his company.
Fiduciary Duties: Counsel to the board of a publicly traded company in a class action alleging fiduciary duty breaches arising out of a proposed $1.2 billion merger.
Counsel to the board of a publicly traded company in a class action alleging fiduciary duty breaches arising out of the company's equity compensation program.
Counsel to an executive of a publicly traded company in a class action alleging fiduciary duty breaches arising out of the company's issuance of dividends.
